Our product
Lieberty logo
liberty product
liberty product

Our innovative solution BactifyTM elevates Gold Standard pathogen cultures by detecting pathogens through their gas biomarkers, streamlining laboratory workflows, eliminating contamination risks, reducing time to results and ensuring smooth lab integration.

Through our novel approach, we are transforming infectious diseases diagnostics using new gas biomarkers, focusing on the clinical market to cut costs, reduce antibiotic use, and save lives.

Our solution promises rapid and precise diagnostics, paving the way for a new era of global health advancements.

Download Brochure

Reduces result time by nearly 50%
(15 hours versus 33 hours using
traditional manual methods)

Enables early microbial detection
or infection alerts, facilitating faster clinical actions

Decreases technician workload and improves overall laboratory turnaround time

Headspace analysis of metabolic Volatile Organic Compounds (VOCs) released by microorganisms during growth

Parameters measured: Concentrations of CO2, O2 and other gases such Azote, Hydrogen, Ammonia, Acetone, Hydrogen sulfide, Methane

Time to Results: Ranging from 12 to 48 hours (pathogen- and inoculum- dependent)

Unmet medical need.

LABORATORY SETTINGS:

> Detection of growth in blood culture bottles is currently done via totally manual methods (subculture onto agar plates) or via automated machinery (e.g. BacTAlertTM, BactecTM), the latter being very expensive – especially for labs in Low- and Middle-Income Countries (LMIC).

> We have developed a semi-automated readout method for blood culture bottles to detect growth by sampling the VOC in the bottle headspace, using a very inexpensive portable equipment and very low-cost reagents (bottle cap and tubing). This would allow microbiology labs with limited resources to decrease the labour associated with reading bottles while speeding up the time to detection of growth which should improve antibiotic stewardship and patient outcomes.



Regulatory Status: WHO Prequalification pending. CE mark and FDA in progress.
Disclaimer: Product not yet available on the market, not for sale.

Read more

Easy integration in the lab workflow






Detection of pathogens through their gas biomarkers


AI enhanced Detection of the pathogen involved








Early detection through the application of volatolomics













Real-time Data Analytics















Diagnostic results on the lab network

Faster Diagnostics. Smarter Treatment Choices

Antibiotic Stewardship. Optimization of Antibiotic Use

Cost-Effective Care Delivery

Advanced Technology. Simplified for Everyone